CLOZAPINE TREATMENT OF SCHIZOPHRENIC-PATIENTS - PLASMA CONCENTRATION AND COAGULATION-FACTORS

被引:40
作者
THORUP, M [1 ]
FOG, R [1 ]
机构
[1] ST HANS HOSP, DEPT E, DK-4000 ROSKILDE, DENMARK
关键词
D O I
10.1111/j.1600-0447.1977.tb00148.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Male chronic schizophrenic hospitalized patients (11), treated with a constant dose of clozapine (200-600 mg daily) as their only neuroleptic medication, were studied for a long period of time (minimum 12 wk). Wide variations in the plasma concentration of clozapine were found in different patients who received the same oral dose, as well as great changes from week to week in the individual patient given a constant dose. The plasma levels of clozapine appeared to have no correlation with either the clinical effect or the side effects. No differences with regard to coagulation factors were found between the patients and the controls.
引用
收藏
页码:123 / 126
页数:4
相关论文
共 13 条
[1]  
ANGST J, 1974, SOMATISCHE THERAPIE, P93
[2]   INCREASED PLATELET-AGGREGATION RESPONSES TO 5-HYDROXYTRYPTAMINE IN PATIENTS TAKING CHLORPROMAZINE [J].
BOULLIN, DJ ;
WOODS, HF ;
GRIMES, RPJ ;
GRAHAMESMITH, DG ;
WILES, D ;
GELDER, MG ;
KOLAKOWSKA, T .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 2 (01) :29-35
[3]   RESUSPENSION OF PLATELETS - ENHANCED 5-HYDROXYTRYPTAMINE-INDUCED AGGREGATION IN CHLORPROMAZINE TREATED PATIENTS DUE TO CHANGES IN PLATELET PROPERTIES [J].
BOULLIN, DJ ;
GRAHAMESMITH, DG ;
GRIMES, RPJ ;
WOODS, HF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 2 (01) :37-39
[4]   EFFECT OF NEUROLEPTIC DRUG TREATMENT ON PLASMA FIBRINOGEN CONCENTRATIONS IN SCHIZOPHRENIC [J].
BRACKENRIDGE, CJ ;
JONES, IH .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1968, 31 (04) :326-+
[5]  
DEGKWITZ R, 1967, LEITFADEN PSYCHOPHAR, P77
[6]  
FOG R, 1972, ACTA NEUROL SCAND, V48, P1
[7]   NEUROLEPTIC ACTION OF CLOZAPINE INJECTED INTO VARIOUS BRAIN AREAS IN RATS [J].
FOG, R .
INTERNATIONAL PHARMACOPSYCHIATRY, 1975, 10 (02) :89-93
[8]  
FOG R, 1976, P DIBENZAZEPINE SEMI
[9]   CLOZAPINE AND HALOPERIDOL IN A SINGLE-BLIND CROSSOVER TRIAL - THERAPEUTIC AND BIOCHEMICAL ASPECTS IN TREATMENT OF SCHIZOPHRENIA [J].
GERLACH, J ;
KOPPELHUS, P ;
HELWEG, E ;
MONRAD, A .
ACTA PSYCHIATRICA SCANDINAVICA, 1974, 50 (04) :410-424
[10]   EXTRAPYRAMIDAL REACTIONS AND AMINE METABOLITES IN CEREBROSPINAL-FLUID DURING HALOPERIDOL AND CLOZAPINE TREATMENT OF SCHIZOPHRENIC-PATIENTS [J].
GERLACH, J ;
THORSEN, K ;
FOG, R .
PSYCHOPHARMACOLOGIA, 1975, 40 (04) :341-350